INEGY 10 MG20 MG TABLETS

Страна: Израиль

Язык: английский

Источник: Ministry of Health

Активный ингредиент:

EZETIMIBE; SIMVASTATIN

Доступна с:

MERCK SHARP & DOHME ISRAEL LTD

код АТС:

C10AA01

Фармацевтическая форма:

TABLETS

состав:

SIMVASTATIN 20 MG; EZETIMIBE 10 MG

Администрация маршрут:

PER OS

Тип рецепта:

Required

Производитель:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Терапевтическая группа:

SIMVASTATIN

Терапевтические области:

SIMVASTATIN

Терапевтические показания :

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Дата Авторизация:

2012-04-30